Seiichi Okabe, Yuya Arai, Akihiko Gotoh. Correspondence to: "Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations", Curik N et al. Leukemia. 2024; 38: 1415-1418. Leukemia. 2025
Shunsuke Otsuki, Seiichiro Katagiri, Yuya Arai, Shohei Wakamatsu, Mituru Moriyama, Akiko Yamada, Tamiko Suguro, Michiyo Asano, Seiichiro Yoshizawa, Daigo Akahane, et al. [Comparison of IPSS-R and IPSS-M in newly diagnosed myelodysplastic neoplasms: a single-center study]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2025. 66. 1. 7-11
Seiichi Okabe, Yuya Arai, Akihiko Gotoh. Targeting the insulin-like growth factor-1 receptor to overcome imatinib resistance in chronic myeloid leukemia. Discover oncology. 2024. 15. 1. 835-835
Seiichi Okabe, Yuya Arai, Akihiko Gotoh. Vitamin K2 Protects Against SARS-CoV-2 Envelope Protein-Induced Cytotoxicity in Chronic Myeloid Leukemia Cells and Enhances Imatinib Activity. International journal of molecular sciences. 2024. 25. 21
Seiichi Okabe, Mitsuru Moriyama, Yuya Arai, Akihiko Gotoh. Glutaminase 1 plays critical roles in myelodysplastic syndrome and acute myeloid leukemia cells. Cancer biomarkers : section A of Disease markers. 2024